Today’s Research Reports on Trending Tickers: Gilead Sciences and Geron Corporation
U.S. markets fell Tuesday on slumping commodity prices, with U.S. crude oil posting its largest one day drop in over a month. The Dow Jones Industrial Average declined 0.13 percent to close at 23,409.47, while the S&P 500 Index fell 0.23 percent to close at 2,578.87. The Nasdaq Composite Index dropped 0.29 percent to close at 6,737.87. On Tuesday, the International Energy Agency said the recent rally in crude oil prices could be short-lived and global demand will be weaker-than-expected for the rest of the year and next.
“Since Friday, the theme has been deleveraging and taking risk off the table,” said Larry Peruzzi, managing director of international equity trading at Mischler Financial, according to The Wall Street Journal. “Part of it has been profit-taking and part of it has been uncertainty with taxes and Washington.”
RDI Initiates Coverage on:
Gilead Sciences, Inc.
Gilead Sciences stock moved 2.33% lower Tuesday, to close the day at $71.15. The stock recorded a trading volume of 10.93 million shares, which was above its three months average volume of 8.34 million shares. In the last year, Gilead Sciences shares have traded in a range of 63.76 – 86.27. The share price has gained 11.59% from its 52 week low. Shares of Gilead Sciences have fallen roughly 12.34 percent in the past month and are down 0.64 percent year-to-date.
Access RDI’s Gilead Sciences, Inc. Research Report at:
On Tuesday, shares in Geron Corporation recorded a trading volume of 5,122,846 shares, which was above the three months average volume of 1,016,029 shares. The stock ended the day 7.69% lower at 1.80. The share price has gained 3.45% from its 52 week low with a 52 week trading range of 1.74 – 3.15.The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $2.13 is less than its 200-day moving average of $2.44. Shares of Geron Corporation have fallen roughly 15.09 percent in the past month and are down 13.04 percent year-to-date.
Access RDI’s Geron Corporation Research Report at:
Our Actionable Research on Gilead Sciences, Inc. (NASDAQ:GILD) and Geron Corporation (NASDAQ:GERN) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.